RBC Capital Sticks to Their Buy Rating for Edgewell Personal Care (EPC)
In a report released today, Nik Modi from RBC Capital maintained a Buy rating on Edgewell Personal Care (EPC – Research Report), with a price ...
4D Molecular Therapeutics (FDMT) Gets a Buy from RBC Capital
RBC Capital analyst Lisa Walter reiterated a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report) today and set a price target of ...
RBC Capital maintains Outperform on Palo Alto Networks stock, $225 target
RBC Capital Markets reaffirmed their positive stance on Palo Alto Networks (NASDAQ:PANW), maintaining an Outperform rating and a $225.00 price target for the cybersecurity company's shares. The stock, ...